Like the creativity Plext... I don't know who to quote a post in another thread, and missed who else may have mentioned it but @chin4 noted "Some have suggested it may be legal to reduce the actual 0.9/1.5 numbers?" as another creative option. He also noted LT's conversion of millions of options at a loss to benefit the company.
If the above were legal (I am not sure whether it would be), I know the company has often portrayed the desire to benefit long-term holders, so I would throw out if they are considering considering out-of-the-box solutions like the above, they may want to recognize those who have spoken with their wallet over those who might have been more concerned about themselves (not pointed, just noting the hedging nature of the ELF which is more self-serving versus those that fronted up and put their cash into the company). As such, another possible option:
-If looking to reduce the 0.9/1.5 numbers, then also consider the ESIOC numbers because those that converted before the A's and particularly the B's before a certain date really were doing it for the benefit of the company (assumption only) for the most part.
Only my thoughts.
- Forums
- ASX - By Stock
- ECT
- Questions for ECT Rep
Questions for ECT Rep, page-31
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
-0.001(14.3%) |
Mkt cap ! $9.515M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $6 | 1.859K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
54 | 14660396 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 12520617 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
54 | 14660396 | 0.003 |
22 | 14565353 | 0.002 |
12 | 18569024 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 12520617 | 23 |
0.005 | 4374813 | 26 |
0.006 | 5239567 | 10 |
0.007 | 1118334 | 6 |
0.008 | 332213 | 4 |
Last trade - 10.02am 16/07/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online